Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 233

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents

Open access
Asshoff, Malte, Petzer, Verena, Warr, Matthew R., Haschka, David, Tymoszuk, Piotr, Demetz, Egon, Seifert, Markus, Posch, Wilfried, Nairz, Manfred, Maciejewski, Pat, Fowles, Peter, Burns, Christopher J., Smith, Gregg, Wagner, Kay-Uwe, Weiss, Guenter, Whitney, J. Andrew, Theurl, Igor · 2017 · Blood

Abstract

Key Points: MMB ameliorates anemia in a rodent anemia of chronic disease model by inhibiting activin receptor-like kinase-2 activity. Hepcidin-dependent ferroportin degradation is independent of JAK2 phosphorylation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2016-09-740092

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 20

  1. Theurl, 2009, Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications, Blood, 113, 5277, 10.1182/blood-2008-12-195651 · DOI · Paper page
  2. Wang, 2005, A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression, Cell Metab, 2, 399, 10.1016/j.cmet.2005.10.010 · DOI · Paper page
  3. Meynard, 2009, Lack of the bone morphogenetic protein BMP6 induces massive iron overload, Nat Genet, 41, 478, 10.1038/ng.320 · DOI · Paper page
  4. Zhao, 2013, Iron regulation by hepcidin, J Clin Invest, 123, 2337, 10.1172/JCI67225 · DOI · Paper page
  5. Steinbicker, 2011, Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice, Blood, 118, 4224, 10.1182/blood-2011-03-339952 · DOI · Paper page
  6. Steinbicker, 2011, Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation, Blood, 117, 4915, 10.1182/blood-2010-10-313064 · DOI · Paper page
  7. Theurl, 2011, Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo, Haematologica, 96, 1761, 10.3324/haematol.2011.048926 · DOI
  8. Tefferi, 2012, One thousand patients with primary myelofibrosis: the mayo clinic experience, Mayo Clin Proc, 87, 25, 10.1016/j.mayocp.2011.11.001 · DOI · Paper page
  9. Pardanani, 2013, Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis, Am J Hematol, 88, 312, 10.1002/ajh.23406 · DOI
  10. Pardanani, 2013, Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis, Leukemia, 27, 1322, 10.1038/leu.2013.71 · DOI · Paper page
  11. Verstovsek, 2010, Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis, N Engl J Med, 363, 1117, 10.1056/NEJMoa1002028 · DOI · Paper page
  12. Parganas, 1998, Jak2 is essential for signaling through a variety of cytokine receptors, Cell, 93, 385, 10.1016/S0092-8674(00)81167-8 · DOI · Paper page
  13. Neubauer, 1998, Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis, Cell, 93, 397, 10.1016/S0092-8674(00)81168-X · DOI · Paper page
  14. De Domenico, 2009, Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2 [published correction appears in Proc Natl Acad Sci USA. 2012;109(19):7583-7586], Proc Natl Acad Sci USA, 106, 3800, 10.1073/pnas.0900453106 · DOI
  15. Krempler, 2004, Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice, Genesis, 40, 52, 10.1002/gene.20063 · DOI
  16. Lee, 2005, Regulation of hepcidin transcription by interleukin-1 and interleukin-6, Proc Natl Acad Sci USA, 102, 1906, 10.1073/pnas.0409808102 · DOI · Paper page
  17. Wrana, 2013, Signaling by the TGFβ superfamily, Cold Spring Harb Perspect Biol, 5, a011197, 10.1101/cshperspect.a011197 · DOI
  18. Besson-Fournier, 2017, Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B, Blood, 129, 533, 10.1182/blood-2016-10-748541 · DOI
  19. Strati, 2014, Clinical significance of microcytosis in patients with primary myelofibrosis, Leuk Res, 38, 1212, 10.1016/j.leukres.2014.08.007 · doi:10.1016/j.leukres.2014.08.007
  20. Vainchenker, 2013, Myelofibrosis, JAK2 inhibitors and erythropoiesis, Leukemia, 27, 1219, 10.1038/leu.2013.72 · DOI

Cited by

See all 233

Metadata

Authors
Asshoff, M., Petzer, V., Warr, M. R., Haschka, D., Tymoszuk, P., Demetz, E., Seifert, M., Posch, W., Nairz, M., Maciejewski, P., Fowles, P., Burns, C. J., Smith, G., Wagner, K.-U., Weiss, G., Whitney, J. A., & Theurl, I.
Venue
Blood
Published
2017-03-30
Volume
129
Issue
13
Pages
1823-1830
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2586215211
Cited by
233
References
12
FWCI
12.49
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents. https://app.cochat.ai/papers/10.1182/blood-2016-09-740092
The paper
Asshoff, M., Petzer, V., Warr, M. R., Haschka, D., Tymoszuk, P., Demetz, E., Seifert, M., Posch, W., Nairz, M., Maciejewski, P., Fowles, P., Burns, C. J., Smith, G., Wagner, K.-U., Weiss, G., Whitney, J. A., & Theurl, I. (2017). Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents. Blood. https://doi.org/10.1182/blood-2016-09-740092

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.